Literature DB >> 10771893

Myoclonus and epilepsies.

N Fejerman1.   

Abstract

The possible associations of myoclonic phenomenae, progressive or non-progressive encephalopathies and epileptic features are reviewed, with special emphasis on pediatric age. This leads to recognize the following five groups of conditions: (1) Myoclonus without encephalopathy and without epilepsy; (2) Encephalopathies with non-epileptic myoclonus; (3) Progressive encephalopathies presenting myoclonus seizures of epileptic syndromes (Progressive myoclonus epilepsies); (4) Epileptic encephalopathies with myoclonic seizures; (5) Myoclonic epilepsies. Within the first group, which also includes physiologic myoclonus, a more thorough description of "Benign sleep myoclonus of newborn" and "Benign myoclonus of early infancy" is given. Characteristics of group 2 are "Kinsbourne Syndrome" and certain types of "Hyperekplexia" which pose interesting differential diagnosis with stimulus-sensitive epilepsies. In group 3, the concept of progressive encephalopathies is stressed. The fourth group refers to severe epilepsies, mainly on infancy and childhood, which lead to mental retardation irrespective of their aetiology. Group 5 comprises the true myoclonic epilepsies, differentiating syndromes recognized as idiopathic--such as "Benign myoclonic epilepsy of infancy" and "Juvenile myoclonic epilepsy"--from those which are cryptogenic and carry a more cautious prognosis--as "Cryptogenic myoclonic and myoclonoastatic epilepsies" and "Severe myoclonic epilepsy of infancy". Other epileptic syndromes not usually considered as myoclonic epilepsies, but presenting sometimes as myoclonic seizures, are finally referred.

Entities:  

Mesh:

Year:  1997        PMID: 10771893     DOI: 10.1007/bf02726110

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  81 in total

1.  Newer drugs for posthypoxic action myoclonus: observations from a well-studied case.

Authors:  S Fahn
Journal:  Adv Neurol       Date:  1986

2.  Status epilepticus of benign partial epilepsies in children: report of two cases.

Authors:  N Fejerman; A M Di Blasi
Journal:  Epilepsia       Date:  1987 Jul-Aug       Impact factor: 5.864

3.  Some clinical and EEG aspects of benign juvenile myoclonic epilepsy.

Authors:  J Asconapé; J K Penry
Journal:  Epilepsia       Date:  1984-02       Impact factor: 5.864

4.  Mumps-induced opsoclonus-myoclonus and ataxia.

Authors:  N Ichiba; Y Miyake; K Sato; M Oda; H Kimoto
Journal:  Pediatr Neurol       Date:  1988 Jul-Aug       Impact factor: 3.372

5.  Glycine encephalopathy.

Authors:  B Dalla Bernardina; J Aicardi; F Goutières; P Plouin
Journal:  Neuropadiatrie       Date:  1979-08

6.  Clinical and EEG asymmetries in juvenile myoclonic epilepsy.

Authors:  M E Lancman; J J Asconapé; J K Penry
Journal:  Epilepsia       Date:  1994 Mar-Apr       Impact factor: 5.864

Review 7.  The neurobiology of the opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli
Journal:  Clin Neuropharmacol       Date:  1992-06       Impact factor: 1.592

8.  Atypical benign partial epilepsy of childhood.

Authors:  J Aicardi; J J Chevrie
Journal:  Dev Med Child Neurol       Date:  1982-06       Impact factor: 5.449

9.  Startle disease or hyperekplexia: further delineation of the syndrome.

Authors:  F Andermann; D L Keene; E Andermann; L F Quesney
Journal:  Brain       Date:  1980-12       Impact factor: 13.501

Review 10.  Progressive myoclonus epilepsies: clinical and genetic aspects.

Authors:  S F Berkovic; J Cochius; E Andermann; F Andermann
Journal:  Epilepsia       Date:  1993       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.